Access to Genetic Counselor Services Act of 2021

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

COVID-19 relief P.L. 111-148 - Patient Protection and Affordable Care Act Health Information Technology Health workforce shortage issues, Title VII and Title VIII of the Public Health Service Act, nursing, graduate nursing education, nursing-managed health clinics Health wellness and prevention programs Research tobacco, e-cigarettes and flavorings University Center for Excellence in Developmental Disabilities Leadership in Education in Neurodevelopmental Disabilities and Related Disorders (LEND) Rural Communities Opioid Response Program Rural Centers of Excellence Veterans Affairs Community Care H.R. 4292 - COVID-19 and Pandemic Response Centers of Excellence Act H.R. 959 - Black Maternal Health Momnibus Act H.R. 4128, S. 2209 - VALID Act H.R. 4151, S. 2238 - FASD Respect Act S. 4348 - FDA Safety and Landmark Advancement Act H.R. 7667 - Food And Drug Amendments of 2022 H.R. 8747 - Assistance for Rural Community Hospitals (ARCH) Act (H.R.8747 S. 4009 - Assistance for Rural Hospital Support Act S.3799 - PREVENT Pandemics Act Metropolitan Anchor Hospital Designation H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for waiving the 4% statutory PAYGO sequester that would force cuts to Medicare and other health programs, and addressing cuts resulting from CMS 2023 Medicare Physician Fee Schedule Rule. Medicare support for Medicare Graduate Medical Education, including the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), bipartisan legislation that would add 14,000 new Medicare-supported graduate medical education (GME) slots. Support for extending CMS's Acute Hospital Care at Home waiver through the Hospital Inpatient Services Modernization Act (H.R. S. 3792/7053), which would extend the waiver for two years beyond the end of the federal public health emergency. Support for the Access to Genetic Counselor Services Act (S. 1450/H.R. 2144) which would allow Medicare to reimburse genetic counselors directly and expand access to these services. . . Ensure that individuals eligible for Medicaid and CHIP have stable and comprehensive health coverage that provides affordable access to high-quality care, and closing coverage and care gaps for critical health and behavioral health services. Support for making CHIP funding permanent, and enacting a nationwide standard to ensure12-month continuous eligibility to children enrolled in CHIP and/or Medicaid.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA); VALID Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1550 - PREVENT HPV Cancers Act H.R. 1557 - Treat and Reduce Obesity Act H.R. 2144 - Access to Genetic Counseling Act H.R. 5377 - Cancer Patient Equity Act

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to public research universities and the hospitals they operate. Access to Genetic Counselor Services Act of 2021 (H.R. 2144). COVID-19 response and testing. VALID Act of 2021 (H.R. 4128/S. 2209), laboratory testing community impacts. ARPA-H. FAAN Act (H.R. 851/S. 246), Title VIII Reauthorization, Nursing Workforce.

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021; S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA); VALID Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1550 - PREVENT HPV Cancers Act H.R. 1557 - Treat and Reduce Obesity Act H.R. 2144 - Access to Genetic Counseling Act H.R. 5377 - Cancer Patient Equity Act

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act. H.R. 4128, the VALID Act S. 2209, the VALID Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to public research universities and the hospitals they operate. Access to Genetic Counselor Services Act of 2021 (H.R. 2144). COVID-19 response and testing. VALID Act of 2021 (H.R. 4128/S. 2209), laboratory testing community impacts. ARPA-H. FAAN Act (H.R. 851/S. 246), Title VIII Reauthorization, Nursing Workforce.

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021; S.4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA); VALID Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Specific Issue Descriptions: Healthcare issues related to clinical laboratories; H.R. 8188/S. 4449, the Saving Access to Laboratory Services Act (SALSA), provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, included as Subtitle C of Title VIII of S. 4348, the FDA Safety and Landmark Advancements Act (FDASLA), provisions relating to FDA oversight of laboratory-developed tests; H.R. 6202, the Telehealth Extension Act, and H.R. 7573/S. 3593, the Telehealth Extension and Evaluation Act, provisions relating to extension of Medicare coverage of telehealth services and limitations on payment for certain laboratory tests; H.R. 8152, the American Data Privacy and Protection Act (ADPPA), provisions relating to data privacy; S. 3799, the PREVENT Pandemics Act, and a draft of the Improving DATA in Public Health Act, provisions relating to demographic data reporting obligations for laboratories; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; H.R. 5030/S. 2706, the DIVERSE Trials Act, provisions relating to enhancing diversity in clinical trials and data collection and reporting by clinical laboratories; H.R. 6000, the Cures 2.0 Act, provisions relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing; H.R. 6875, the Right Drug Dose Now Act, provisions relating to use of pharmacogenetic information; H.R. 2565/S. 2952, the FDA Modernization Act, provisions relating to biomedical research; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; Federal policy relating to the National Correct Coding Initiative and manual instructions inconsistent with American Medical Association guidelines for Current Procedural Terminology (CPT) coding; and Federal policy relating to availability of Current Procedural Terminology (CPT) codes.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1550 - PREVENT HPV Cancers Act H.R. 1557 - Treat and Reduce Obesity Act H.R. 2144 - Access to Genetic Counseling Act H.R. 5377 - Cancer Patient Equity Act

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to public research universities and the hospitals they operate. Access to Genetic Counselor Services Act of 2021 (H.R. 2144). COVID-19 response and testing. VALID Act of 2021 (H.R. 4128/S. 2209), laboratory testing community impacts. ARPA-H. FAAN Act (H.R. 851/S. 246), Title VIII Reauthorization, Nursing Workforce.

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers and patients, including related provisions in S. 3799, the PREVENT Pandemics Act, and monitor implementation of H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and S. 1666, the Verified Innovative Testing in American Laboratories Act (VITAL Act) of 2021; and H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA).

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1550 - PREVENT HPV Cancers Act H.R. 1557 - Treat and Reduce Obesity Act H.R. 2144 - Access to Genetic Counseling Act H.R. 5377 - Cancer Patient Equity Act

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 6202, the Telehealth Extension Act, and S. 3593, the Telehealth Extension and Evaluation Act, provisions relating to extension of Medicare coverage of telehealth services and limitations on payment for certain laboratory tests; S. 3534, the Tracking Pathogens Act, provisions relating to genomic sequencing of variants of the SARS-CoV-2 virus; S. 3799, the PREVENT Pandemics Act, and a draft of the Improving DATA in Public Health Act, provisions relating to demographic data reporting obligations for laboratories; Federal policy related to the National Correct Coding Initiative and manual instructions inconsistent with American Medical Association guidelines for Current Procedural Terminology (CPT) coding; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; H.R. 4144/S. 2022, the Ending the Diagnostic Odyssey Act, provisions relating to coverage of whole genome sequencing services for certain individuals; H.R. 5030/S. 2706, the DIVERSE Trials Act, provisions relating to enhancing diversity in clinical trials and data collection and reporting by clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 6000, the Cures 2.0 Act, provisions relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing; H.R. 4144/S. 2022, the Ending the Diagnostic Odyssey Act, provisions relating to coverage of whole genome sequencing services for certain individuals; and H.R. 6875, the Right Drug Dose Now Act, provisions relating to use of pharmacogenetic information; H.R. 2565/S. 2952, the FDA Modernization Act, provisions relating to biomedical research; and Federal policy relating to CDC funding for standardization of pediatric reference range intervals and laboratory result harmonization.

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Expressed support for extending both the sequester moratorium and the Medicare physician payment adjustment Expressed support for Access to Genetic Counselor Services Act (H.R.2144) within CURES 2.0 legislation Expressed support for NIHs National COVID Cohort Collaborative

Client expense: $100,877 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Advocacy on health care issues related to genetics and genetic testing, including H.R. 482 / S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 1439; the Expanded Genetic Screening Act; and H.R. 2144 / S. 1450, to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Advocate for Medicare reimbursement for genetic counselors. H.R.2144, the Access to Genetic Counselors Act. S. 1450, the Access to Genetic Counselors Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes, all provisions H.R. 315, Medicare Sequester COVID Moratorium Act, all provisions S. 748, Medicare Sequester Relief Act, all provisions H.R. 5612, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions H.R. 6020, Supporting Medicare Providers Act of 2021, all provisions S. 3314, Supporting Medicare Providers Act of 2021, all provisions S. 610, Protecting Medicare and American Farmers from Sequester Cuts Act, provisions relating to averting Medicare physician fee schedule cuts H.R. 6144, Removing Waste and Protecting Medicare Act, all provisions H.R. 6048, Medicare Stability for Patients and Providers Act, all provisions H.R. 1332, Telehealth Modernization Act, provisions related to permanently lifting Medicare telehealth restrictions S. 368, Telehealth Modernization Act, provisions related to permanently lifting Medicare telehealth restrictions H.R. 2903, CONNECT for Health Act of 2021, provisions related to permanently lifting Medicare telehealth restrictions S. 1512, CONNECT for Health Act of 2021, provisions related to permanently lifting Medicare telehealth restrictions H.R. 366, Protecting Access to Post-COVID-19 Telehealth Act of 2021, all provisions H.R. 4058, Telemental Health Care Access Act of 2021, provisions related to permanently lifting Medicare telehealth restrictions S. 2061, Telemental Health Care Access Act of 2021, provisions related to permanently lifting Medicare telehealth restrictions H.R. 2166, Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021, all provisions H.R. 2228, Rural Behavioral Health Access Act of 2021, all provisions H.R. 3447, Permanency for Audio-Only Telehealth Act, all provisions H.R. 6000, Cures 2.0 Act, all provisions H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions S. 3039, Social Determinants Accelerator Act of 2021, all provisions H.R. 3173, Improving Seniors Timely Access to Care Act of 2021, all provisions S. 3018, Improving Seniors Timely Access to Care Act of 2021, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 3259, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, all provisions S. 586, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, all provisions S. 987, CARA 3.0 Act of 2021, all provisions S. 1438, Opioid Workforce Act of 2021, all provisions H.R. 3441, Substance Use Disorder Workforce Act, all provisions H.R. 3407, MOMMAs Act, all provisions S. 411, MOMMAs Act, all provisions H.R. 925, Data to Save Moms Act, all provisions H.R. 3352, Midwives for MOMS Act of 2021, all provisions H.R. 2256, Resident Physician Shortage Reduction Act of 2021, all provisions S. 834, Resident Physician Shortage Reduction Act of 2021, all provisions H.R. 4014, Physician Shortage GME Cap Flex Act of 2021, all provisions S. 2094, Physician Shortage GME Cap Flex Act of 2021, all provisions H.R. 3746, Accountable Care in Rural America Act, all provisions H.R. 4587, Value in Health Care Act of 2021, all provisions H.R. 4755, Seniors Chronic Care Management Improvement Act of 2021, all provisions H.R. 6308, ACO Assignment Improvement Act of 2021, all provisions H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions H.R. 19, Lower Costs, More Cures Act of 2021, all provisions H.R. 4034, Ensuring Patient Access to Critical Breakthrough Products Act of 2021, all provisions S. 2416, New Opportunities for Value that Extend Lives (NOVEL) Act of 2021, all provisions H.R. 2144, Access to Genetic Counselor Services Act of 2021, provisions relating to scope of practice S. 1450, Access to Genetic Counselor Services Act of 2021, provisions relating to scope of practice H.R. 2654, Chiropractic Medicare Coverage Modernization Act of 2021, provisions relating to scope of practice H.R. 2305, Improving Access to Mental Health Act of 2021, all provisions H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act, all provisions S. 801, Connected MOM Act, all provisions S. 346, Black Maternal Health Momnibus Act of 2021, all provisions H.R. 1738, Stabilize Medicaid and CHIP Coverage Act, all provisions H. R. 1025, Kids Access to Primary Care Act of 2021, all provisions H.R. 66, Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids Act, all provisions H.R. 955, Medicaid Reentry Act of 2021, all provisions S. 285, Medicaid Reentry Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, provisions relating to Medicare and Medicaid S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, provisions relating to Medicare and Medicaid Medicare program: No Surprises Act/implementation Medicare program: CY 2021 Physician Fee Schedule/3.75% payment adjustment Medicare program: Physician Payment Reform Medicare program: 2022 physician payment Medicare program: Alternative payment models (APMs) Medicare program: Health equity Medicare program: Medicare Diabetes Prevention Program Medicare program: Prescription drug prices Medicare program: Cybersecurity Medicare program: Medicare expansion/dental, vision, hearing coverage Medicare program: Physician payment/PAYGO and sequester Medicare program: Barriers to patient care Medicare program: 2020 Physician spending/COVID-19 Impact Medicare program: Evaluation and Management (E/M)/budget neutrality Medicare program: Pharmacy Benefit Managers/Rx drug price transparency Medicare program: Merit-Based Incentive Payment System (MIPS) program Medicare program: MIPS/Value Pathways (MVPs) Medicare program: MIPS/cost, promoting interoperability, improvement activities Medicare program: Quality Payment Program (QPP) Medicare program: Health IT physician burdens Medicare program: Primary Care First models Medicare program: Medicare Shared Savings Program (MSSP) Medicare program: Open Payments Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS) Enrollment/Revalidation Medicare program: Telehealth policies Medicare program: RVS Update Committee (RUC) - physician payment Medicare program: Coding - CPT Panel Medicare program: Accountable Care Organizations (ACOs)/Pre-COVID Benchmarks Medicare program: Federal Gold Carding Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/implementation/Accountable Care Organizations Medicare and Medicaid programs: MACRA Oversight Medicare and Medicaid programs: MACRA physician burdens Medicare and Medicaid programs: Prior authorization Medicare and Medicaid programs: COVID-19 public health emergency/accelerated and advance payments Medicare and Medicaid programs: Electronic funds transfer (EFT) standard/Enforcement Medicare and Medicaid programs: Provider Relief Fund Medicare and Medicaid programs: Telehealth Extension and Evaluation Act/draft Medicare and Medicaid programs: Telehealth and Dialysis centers Medicare and Medicaid programs: COVID-19 telehealth flexibilities continuation Medicare and Medicaid programs: Primary and Virtual Health Care Affordability Act Medicare and Medicaid programs: Data Privacy Medicare and Medicaid programs: Social determinants of health Medicare and Medicaid programs: Information blocking/privacy Medicare and Medicaid programs: Information blocking/privacy of adolescents Medicare and Medicaid programs: Opioids Medicaid program: Medicaid funding in U.S. Territories Medicaid program: Medicaid expansion Medicaid program: Maternal mortality Medicaid program: COVID-19/uninsured healthcare coverage Medicaid program: Medicaid Special Enrollment Period

Client expense: $4,770,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counselor services in H.R. 6000, the Cures 2.0 Act, Section 408, regarding Medicare coverage of pharmacogenetic consultations. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 834 - Resident Physician Shortage Reduction Act of 2021 H.R. 2144 - Access to Genetic Counselor Services Act

Client expense: $88,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office

H.R.5989 - Precision Medicine Answers for Kids Today Act H.R. 2144, Access to Genetic Counselor Services Act H.R. 2903 CONNECT for Health Act H.R. 708, TREAT Act H.R.6202 - Telehealth Extension Act of 2021 Molecular Pathology Coding and Reimbursement Oncology Care Model

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 2144 - genetic counselors coverage under part B HR 853- Closing Loopholes for Orphan Drug Act S. 368 - Telehealth Modernization Act HR 3441- Substance Use Disorder Workforce Act S. 1438 - Opioid Workforce Act

Client expense: $15,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; S. 610, the Protecting Medicare and American Farmers from Sequester Cuts Act, provisions relating to delays in data collection and rate changes pertinent to the Medicare Clinical Laboratory Fee Schedule, mitigation of the Medicare sequester and rate changes pertinent to the Medicare Physician Fee Schedule, and suspension of certain statutory pay-as-you-go requirements; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; H.R. 5030/S. 2706, the DIVERSE Trials Act, provisions relating to enhancing diversity in clinical trials and data collection and reporting by clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 6000, the Cures 2.0 Act, provisions relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing; S. 1605, the National Defense Authorization Act for Fiscal Year 2022, provisions relating to TRICARE coverage of preconception and prenatal carrier screening; H.R. 4144/S. 2022, the Ending the Diagnostic Odyssey Act, provisions relating to coverage of whole genome sequencing services for certain individuals; and Federal policy relating to use of pharmacogenetic information, including a discussion draft of the Right Drug Dose Now Act.

Client expense: $840,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 4393 - Advancing Precision Medicine Act; H.R. 3783, S. 2013 - Medical Nutrition Equity Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1550 - PREVENT HPV Cancers Act H.R. 1557 - Treat and Reduce Obesity Act H.R. 2144 - Access to Genetic Counseling Act H.R. 5377 - Cancer Patient Equity Act

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Enhance Medicare beneficiary access to genetic counseling services, including related provisions in H.R. 2144, and S. 1450, the Access to Genetic Counselor Services Act, to amend the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under Medicare Part B; and related provisions regarding genetic counseling and genetic counselor services in draft legislation, Cures 2.0. Coronavirus response efforts, including support for health care providers, patients, and implementation of related provisions in H.R. 1319, the American Rescue Plan Act, P.L. 117-2.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Access to Genetic Counselor Services Act (H.R. 2144) Analyzing the Duration of Remote Monitoring Services Act of 2021 (H.R.4347) CONNECT for Health Act of 2021 (H.R.2903 / S.1512) Increasing Access to Quality Cardiac Rehabilitation Care Act of 2021 (S.1986) Medicare Dental Benefit Act of 2021 (S.97 / H.R. 502 SAME Act of 2021 (S.245) SOS: Sustaining Outpatient Services Act (H.R.3348) Medicaid Waivers National Coverage Determination for Self-Measured Blood Pressure Requirements Related to Surprise Billing Part I & Part II The Telehealth Modernization Act (S.368) 2022 Hospital Inpatient Prospective Payment System 2022 Hospital Outpatient Prospective Payment System 2022 Physician Fee Schedule

Client expense: $140,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office